These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26273831)

  • 1. Coaxial Electrospray of Ranibizumab-Loaded Microparticles for Sustained Release of Anti-VEGF Therapies.
    Zhang L; Si T; Fischer AJ; Letson A; Yuan S; Roberts CJ; Xu RX
    PLoS One; 2015; 10(8):e0135608. PubMed ID: 26273831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.
    Joseph RR; Tan DWN; Ramon MRM; Natarajan JV; Agrawal R; Wong TT; Venkatraman SS
    Sci Rep; 2017 Dec; 7(1):16803. PubMed ID: 29196745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single ocular injection of a sustained-release anti-VEGF delivers 6months pharmacokinetics and efficacy in a primate laser CNV model.
    Adamson P; Wilde T; Dobrzynski E; Sychterz C; Polsky R; Kurali E; Haworth R; Tang CM; Korczynska J; Cook F; Papanicolaou I; Tsikna L; Roberts C; Hughes-Thomas Z; Walford J; Gibson D; Warrack J; Smal J; Verrijk R; Miller PE; Nork TM; Prusakiewicz J; Streit T; Sorden S; Struble C; Christian B; Catchpole IR
    J Control Release; 2016 Dec; 244(Pt A):1-13. PubMed ID: 27810558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy.
    Chobisa D; Muniyandi A; Sishtla K; Corson TW; Yeo Y
    Small; 2024 Mar; 20(10):e2306479. PubMed ID: 37940612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidics-derived hierarchical microparticles for the delivery of dienogest for localized endometriosis therapy.
    Wu M; Zhang Q; Shang L; Duan P
    Acta Biomater; 2024 Apr; 178():257-264. PubMed ID: 38387747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Eylea® with Lucentis® as first-line therapy in patients with treatment-naïve neovascular age-related macular degeneration in real-life clinical practice: retrospective case-series analysis.
    Böhni SC; Bittner M; Howell JP; Bachmann LM; Faes L; Schmid MK
    BMC Ophthalmol; 2015 Aug; 15():109. PubMed ID: 26289356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Choroidal Topographic Changes by Swept-Source Optical Coherence Tomography After Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration.
    Razavi S; Souied EH; Darvizeh F; Querques G
    Am J Ophthalmol; 2015 Nov; 160(5):1006-13. PubMed ID: 26275471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of endophthalmitis after intravitreal application of anti VEGF therapy at the University Clinical Center in Tuzla, Bosnia and Herzegovina.
    Terzić S; Pilavdžić A; Nadarević Vodenčarević A
    Med Glas (Zenica); 2015 Aug; 12(2):202-5. PubMed ID: 26276660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing.
    Szabo SM; Hedegaard M; Chan K; Thorlund K; Christensen R; Vorum H; Jansen JP
    Curr Med Res Opin; 2015 Nov; 31(11):2031-42. PubMed ID: 26296050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment Patterns of Anti-Vascular Endothelial Growth Factor and Laser Therapy Among Patients with Diabetic Macular Edema.
    Jiang S; Barner JC; Park C; Ling YL
    J Manag Care Spec Pharm; 2015 Sep; 21(9):735-41. PubMed ID: 26308221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aflibercept administration in neovascular age-related macular degeneration refractory to previous anti-vascular endothelial growth factor drugs: a critical review and new possible approaches to move forward.
    Lazzeri S; Ripandelli G; Sartini MS; Parravano M; Varano M; Nardi M; Di Desidero T; Orlandi P; Bocci G
    Angiogenesis; 2015 Oct; 18(4):397-432. PubMed ID: 26346237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-year patient-reported visual function outcomes in diabetic macular edema managed with ranibizumab: the RESTORE extension study.
    Mitchell P; Massin P; Bressler S; Coon CD; Petrillo J; Ferreira A; Bressler NM
    Curr Med Res Opin; 2015 Nov; 31(11):1967-75. PubMed ID: 26327116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraocular Pharmacokinetics of Aflibercept and Vascular Endothelial Growth Factor-A.
    Celik N; Scheuerle A; Auffarth GU; Kopitz J; Dithmar S
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5574-8. PubMed ID: 26305529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranibizumab for Visual Impairment due to Diabetic Macular Edema: Real-World Evidence in the Italian Population (PRIDE Study).
    Menchini U; Bandello F; De Angelis V; Ricci F; Bonavia L; Viola F; Muscianisi E; Nicolò M
    J Ophthalmol; 2015; 2015():324841. PubMed ID: 26294963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between Intravitreal Steroids and Post-Injection Endophthalmitis Rates.
    VanderBeek BL; Bonaffini SG; Ma L
    Ophthalmology; 2015 Nov; 122(11):2311-2315.e1. PubMed ID: 26281823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual functioning and health-related quality of life in diabetic patients about to undergo anti-vascular endothelial growth factor treatment for sight-threatening macular edema.
    Granström T; Forsman H; Leksell J; Jani S; Raghib AM; Granstam E
    J Diabetes Complications; 2015; 29(8):1183-90. PubMed ID: 26318959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paradigm shift in imaging biomarkers in neovascular age-related macular degeneration.
    Schmidt-Erfurth U; Waldstein SM
    Prog Retin Eye Res; 2016 Jan; 50():1-24. PubMed ID: 26307399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.
    Polizzi S; Mahajan VB
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):605-10. PubMed ID: 26302032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The progress in understanding and treatment of diabetic retinopathy.
    Stitt AW; Curtis TM; Chen M; Medina RJ; McKay GJ; Jenkins A; Gardiner TA; Lyons TJ; Hammes HP; Simó R; Lois N
    Prog Retin Eye Res; 2016 Mar; 51():156-86. PubMed ID: 26297071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Therapies in Development for Diabetic Macular Edema.
    Agarwal A; Afridi R; Hassan M; Sadiq MA; Sepah YJ; Do DV; Nguyen QD
    Curr Diab Rep; 2015 Oct; 15(10):75. PubMed ID: 26294336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.